Episome-Generated N-myc Antisense RNA Restricts the Differentiation Potential of Primitive Neuroectodermal Cell Lines

REFERENCES

• Akeson, R., and R. Bernards. 1990. N-myc down regulates neural cell adhesion molecule expression in rat neuroblastoma. Mol. Cell. Biol. 10:2012-2016.
   PubMed Web of Science ®Google Scholar
• Andrews, P. W. 1984. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 103:285-293.
   PubMed Web of Science ®Google Scholar
• Charron, J., B. A. Malynn, E. J. Robertson, S. P. Goff, and F. W. Alt. 1990. High frequency disruption of the N-myc gene in embryonic stem and pre-B cell lines by homologous recombination. Mol. Cell. Biol. 10:1799-1804.
   PubMedGoogle Scholar
• Ciccarone, V. C., B. A. Spengler, M. B. Meyers, J. L. Biedler, and R. A. Ross. 1989. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res. 49:219-225.
   PubMed Web of Science ®Google Scholar
• Collum, R. G., and F. W. Alt. 1990. Are myc proteins transcription factors? Cancer Cells 2:69-75.
   PubMedGoogle Scholar
• Finklestein, R., and R. Weinberg. 1988. Differential regulation of N-myc and c-myc expression in F9 teratocarcinoma cells. Oncogene Res. 3:287-292.
   PubMedGoogle Scholar
• Groger, R. K., D. M. Morrow, and M. L. Tykocinski. 1989. Directional antisense and sense cDNA cloning using Epstein-Barr virus episomal expression vectors. Gene 81:285-294.
   PubMed Web of Science ®Google Scholar
• Hambor, J. E., C. A. Hauer, H. Shu, R. K. Groger, D. R. Kaplan, and M. L. Tykocinski. 1988. Use of an Epstein-Barr virus episomal replicon for antisense RNA-mediated gene inhibition in a human cytotoxic T-cell clone. Proc. Natl. Acad. Sci. USA 85:4010-4014.
   PubMedGoogle Scholar
• Holt, J. T., T. V. Gopal, A. D. Moulton, and A. W. Nienhuis. 1986. Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc. Natl. Acad. Sci. USA 83:4794-4798.
   PubMed Web of Science ®Google Scholar
• Ikegaki, N., J. Bukovsky, and R. H. Kennett. 1986. Identification and characterization of the N-myc gene product in human neuroblastoma cells by monoclonal antibodies with defined specificities. Proc. Natl. Acad. Sci. USA 83:5929-5933.
   PubMedGoogle Scholar
• Kato, K., A. Kanamori, and H. Kondoh. 1990. Rapid and transient decrease of N-myc expression in retinoic acid-induced differentiation of OTF9 teratocarcinoma stem cells. Mol. Cell. Biol. 10:486-491.
   PubMedGoogle Scholar
• Kohl, N. E., N. Kanda, R. R. Schreck, G. Bruns, S. A. Latt, F. Gilbert, and F. W. Alt. 1983. Transposition and amplification of oncogene related sequences in human neuroblastomas. Cell 35:359-367.
   PubMed Web of Science ®Google Scholar
• Lee, W., A. L. Murphree, and W. F. Benedict. 1984. Expression and amplification of the N-myc gene in primary retinoblastoma. Nature (London) 309:458-460.
   PubMed Web of Science ®Google Scholar
• Lutfalla, G., L. Armbruster, S. Dequin, and R. Bertolotti. 1989. Construction of an EBNA-producing line of well-differentiated hepatoma cells and of appropriate Epstein-Barr virus-based shuttle vectors. Gene 76:27-39.
   PubMedGoogle Scholar
• Matsumura, T., T. Sugimoto, and T. Sawada. 1988. Phenotypes of neuroblastoma cells as distinguished by monoclonal antibodies, p. 38-55. In M. Sluyser and P. A. Voute (ed.), Molecular biology and genetics of childhood cancers: approaches to neuroblastoma. Ellis Horwood Limited, Chichester, West Sussex, England.
   Google Scholar
• Michitsch, R. W., J. L. Biedler, and P. W. Melera. 1988. Modulation of N-myc expression, but not tumorigenicity accompanies phenotypic conversion of neuroblastoma cells in prolonged culture, p. 103-120. In A. E. Evans, G. J. D’Angio, A. G. Knudson, and R. C. Seeger (ed.), Advances in neuroblastoma research 2. Alan R. Liss, New York.
   Google Scholar
• Mugrauer, G., F. W. Alt, and P. Ekblom. 1988. N-myc protooncogene expression during embryogenesis in the developing mouse as revealed by in situ hybridization. J. Cell Biol. 107:1325-1335.
   PubMed Web of Science ®Google Scholar
• Nakajima, H., M. Ikeda, N. Tsuchida, S. Nishimura, and Y. Taya. 1989. Inactivation of the N-myc gene product by single amino acid substitution of leucine residues located in the leucine-zipper region. Oncogene 4:999-1002.
   PubMedGoogle Scholar
• Nau, M. M., B. J. Brooks, D. N. Carney, A. F. Gazdar, J. F. Battey, E. A. Sausville, and J. D. Minna. 1986. Human small-cell lung cancers show amplification and expression of the N-myc gene. Proc. Natl. Acad. Sci. USA 83:1092-1096.
   PubMed Web of Science ®Google Scholar
• Rettig, W. J., B. A. Spengler, P. G. Chesa, L. J. Old, and J. L. Biedler. 1987. Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res. 47:1383-1389.
   PubMed Web of Science ®Google Scholar
• Rosen, N., C. P. Reynolds, C. J. Thiele, J. L. Biedler, and M. A. Israel. 1986. Increased N-myc expression following progressive growth of human neuroblastoma. Cancer Res. 46:4139-4142.
   PubMed Web of Science ®Google Scholar
• Rosolen, A., L. Whitesell, N. Ikegaki, R. H. Kennett, and L. M. Neckers. 1990. Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line. Cancer Res. 50:6316-6322.
   PubMedGoogle Scholar
• Ross, R. A., V. Ciccarone, M. B. Meyers, B. A. Spengler, and J. L. Biedler. 1988. Differential expression of intermediate filaments and fibronectin in human neuroblastoma cells, p. 277-289. In A. E. Evans, G. J. D’Angio, A. G. Knudson, and R. C. Seeger (ed.), Advances in neuroblastoma research 2. Alan R. Liss, New York.
   Google Scholar
• Ross, R. A., B. A. Spengler, and J. L. Biedler. 1983. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst. 71:741-747.
   PubMed Web of Science ®Google Scholar
• Schlesinger, H. R., J. M. Gerson, P. S. Moorhead, H. Maguire, and K. Hummeler. 1976. Establishment and characterization of human neuroblastoma cell lines. Cancer Res. 36:3094-3100.
   PubMedGoogle Scholar
• Schwab, M., K. Alitalo, K. Klempnauer, H. E. Varmus, J. M. Bishop, F. Gilbert, G. Brodeur, M. Goldstein, and J. Trent. 1983. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature (London) 305:245-248.
   PubMed Web of Science ®Google Scholar
• Seeger, R. C., G. M. Brodeur, H. Sather, A. Dalton, S. E. Siegel, K. Y. Wong, and D. Hammond. 1985. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med. 313:1111-1116.
   PubMed Web of Science ®Google Scholar
• Thiele, C. J., C. P. Reynolds, and M. A. Israel. 1985. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature (London) 313:404-406.
   PubMed Web of Science ®Google Scholar
• Tumilowicz, J. J., W. W. Nichols, J. J. Cholon, and A. E. Greene. 1970. Definition of a continuous human cell line derived from neuroblastoma. Cancer Res. 30:2110-2118.
   PubMed Web of Science ®Google Scholar
• Yancopoulos, G. D., P. D. Nissen, A. Tesfaye, N. E. Kohl, M. P. Goldfarb, and F. W. Alt. 1985. N-myc can cooperate with ras to transform normal cells in culture. Proc. Natl. Acad. Sci. USA 82:5455-5459.
   PubMed Web of Science ®Google Scholar
• Yates, J. L., N. Warren, and W. Sugden. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature (London) 313:812-815.
   PubMed Web of Science ®Google Scholar
• Zimmerman, K. A., G. D. Yancopoulos, R. G. Collum, R. K. Smith, N. E. Kohl, K. A. Denis, M. M. Nau, O. N. Witte, D. Toran-Allerand, C. E. Gee, J. D. Minna, and F. W. Alt. 1986. Differential expression of myc family genes during murine development. Nature (London) 319:780-783.
   PubMed Web of Science ®Google Scholar